CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NBS's Revenue Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
NBS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 10.18 7.56 5.28
III Quarter September - 9.32 5.89 4.12
II Quarter June - 8.30 5.87 4.49
I Quarter March 7.92 7.49 3.17 4.06
FY   7.92 35.29 22.49 17.95

Financial Statements
Caladrius Biosciences,'s first quarter 2017 Revenue $ 7.92 millions NBS's Income Statement
Caladrius Biosciences,'s first quarter 2016 Revenue $ 7.49 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 34.66 % 43.18 % 29.41 %
III Quarter September - 58.23 % 42.96 % 11.05 %
II Quarter June - 41.4 % 30.73 % 2.98 %
I Quarter March 5.78 % 136.28 % -21.92 % 61.11 %
FY   - 56.91 % 25.29 % -



NBS Revenue Growth Comment
Caladrius Biosciences, Inc. reported Revenue growth of 5.78% year on year in the first quarter, to $ 7.92 millions, this is lower than Caladrius Biosciences, Inc.'s recent average Revenue improvement of 24.99%.

Looking into first quarter results within Biotechnology & Drugs industry 41 other companies have achieved higher Revenue growth. While Caladrius Biosciences, Inc.' s Revenue increase of 5.78% ranks overall at the positon no. 1850 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #42
Healthcare Sector #245
S&P 500 #1850
Revenue Y/Y Growth Statistics
High Average Low
136.09 % 24.99 % -88.56 %
(Mar 31 2016)   (Mar 31 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NBS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NBS's Competitors
Revenue Growth for Caladrius Biosciences,'s Suppliers
Revenue Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Intricon Corp  10.02 %$ 10.023 millions
Boston Scientific Corporation  9.98 %$ 9.980 millions
Bio-techne Corp  9.97 %$ 9.975 millions
K2m Group Holdings, Inc.  9.91 %$ 9.908 millions
Regeneron Pharmaceuticals Inc  9.84 %$ 9.838 millions
Abbvie Inc.  9.73 %$ 9.735 millions
Addus Homecare Corp  9.72 %$ 9.723 millions
Integra Lifesciences Holdings Corp  9.24 %$ 9.235 millions
Proteo Inc  8.67 %$ 8.669 millions
National Research Corporation  8.63 %$ 8.633 millions
Nxstage Medical, Inc.  8.53 %$ 8.531 millions
Diplomat Pharmacy, Inc.  8.32 %$ 8.321 millions
Pharmerica Corp  8.06 %$ 8.065 millions
Pressure Biosciences Inc  8.01 %$ 8.008 millions
Integrity Applications, Inc.  7.95 %$ 7.953 millions
Horizon Pharma Plc  7.90 %$ 7.899 millions
Bovie Medical Corp  7.90 %$ 7.897 millions
Icon Plc  7.85 %$ 7.848 millions
Pieris Pharmaceuticals, Inc.  7.75 %$ 7.753 millions
Endo International Plc  7.69 %$ 7.686 millions
Bard C R Inc  7.48 %$ 7.476 millions
Lilly Eli & Co  7.47 %$ 7.465 millions
Fonar Corporation  7.46 %$ 7.460 millions
Juniper Pharmaceuticals Inc  7.35 %$ 7.349 millions
Hill-rom Holdings, Inc.  7.32 %$ 7.319 millions
Surgery Partners, Inc.  7.15 %$ 7.155 millions
Healthsouth Corp  7.14 %$ 7.144 millions
Rockwell Medical, Inc.  7.08 %$ 7.083 millions
Vycor Medical Inc  7.08 %$ 7.077 millions
Universal Hospital Services Inc  6.98 %$ 6.981 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
GHDC's Profile
Stock Price
GHDC's Financials
GHDC's Expectations
Business Description
Fundamentals
Charts & Quotes
GHDC's News
Suppliers
GHDC's Competitors
Customers & Markets
Economic Indicators
GHDC's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com